Physician profile
Layne A Dameron
NPI 1639249782
$3,160.43
in general payments reported to CMS, 2019-2025
27 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $111 · 2021: $802 · 2022: $811 · 2023: $264 · 2024: $550 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $854.70 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $621.26 | 2021 | |
| Stryker Corporation | $240.53 | 2022-2024 | Prostep Mica, Augment Injectable, Allopure |
| Globus Medical, INC. | $196.89 | 2025 | Senza |
| Nevro Corp. | $184.46 | 2021-2024 | Senza |
| Avita Medical Americas, LLC | $140.38 | 2025 | Recell, Cohealyx, Permeaderm |
| Paratek Pharmaceuticals, INC. | $98.10 | 2020-2025 | Nuzyra |
| Amgen INC. | $88.83 | 2024-2025 | Krystexxa |
| Wright Medical Technology, INC. | $83.83 | 2019 | |
| Treace Medical Concepts, INC. | $80.43 | 2024-2025 | |
| Tactile Systems Technology INC | $75.22 | 2019-2021 | |
| Flower Orthopedics Coporation | $70.56 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $50.75 | 2022-2023 | Seglentis |
| Orthofix Medical, INC. | $50.71 | 2020-2022 | |
| Organogenesis INC. | $40.46 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $40.38 | 2021-2025 | Renasys |
| Averitas Pharma INC. | $31.62 | 2023 | Qutenza |
| Mimedx Group, INC. | $28.22 | 2025 | |
| Curonix LLC | $26.83 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medela LLC | $24.57 | 2020 | |
| Horizon Therapeutics Plc | $23.83 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.04 | 2023 | |
| Paragon 28, INC. | $21.59 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.80 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.28 | 2025 | Jublia |
| Bioventus LLC | $13.34 | 2019 | |
| Goode Surgical INC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Layne Dameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.